AL
Alumis Inc.
ALMS · NASDAQ
$9.90 -6.16% (-$0.65)
1M -61.25%
Market Cap $1.22B
P/E Ratio -
Div. Yield -
ROE 102.97%
Piotroski F-Score Weak
2/9Valuation
36 /100
Fair P/S 165.18x
P/B 2.70x
P/E N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 88.23%
Net margin 5,933.45%
Op. margin 6,204.39%
Quality
0 /100
Poor ROIC 93.45%
ROE 102.97%
ROA 78.30%
Debt
100 /100
Low Debt/Equity 0.08x
Current ratio 6.74x
Int. coverage N/A
Stability
19 /100
Unstable Beta -0.67x
EPS volatility 186.73%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ALMS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Martin Babler
Employees
237
Headquarters
South San Francisco
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report